Does Intravitreal Injections of Bevacizumab for Age-related Macular Degeneration Affect Long-term Intraocular Pressure?

A LACK OF DELAYED INTRAOCULAR PRESSURE ELEVATION IN PATIENTS TREATED WITH INTRAVITREAL INJECTION OF BEVACIZUMAB AND RANIBIZUMAB

(2012) Sarah J. Wehrli et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

Sustained Increased Intraocular Pressure Related to Intravitreal Antivascular Endothelial Growth Factor Therapy for Neovascular Age-related Macular Degeneration

(2011) Joseph J. Tseng et al.   JOURNAL OF GLAUCOMA

Sustained elevation of intraocular pressure after intravitreal injections of anti-VEGF agents

(2010) T. J. Good et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Complications of intravitreal injections

(2010) Kapil M Sampat et al.   CURRENT OPINION IN OPHTHALMOLOGY

Sustained Elevation in Intraocular Pressure Associated with Intravitreal Bevacizumab Injections

(2009) Malik Y. Kahook et al.   OPHTHALMIC SURGERY LASERS & IMAGING

Antiangiogenic Approaches to Age-Related Macular Degeneration Today

(2009) Neil M. Bressler   OPHTHALMOLOGY

Short-term Intraocular Pressure Changes Immediately After Intravitreal Injections of Anti–Vascular Endothelial Growth Factor Agents

(2008) Judy E. Kim et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY